What would share price be if Spectral didn't keep secrets?It's hard to believe, but it seems every time a large Medical Co. has decided to partner with or invested in Spectral it needs to be kept secret.
Baxter Exclusive Distribution Deal:
Announced Feb. 4 2020
3 milestone payments. The dollar amount of two payments- kept secret.
"Confirmed Partner #2"
Announced June 22 2022
Name of company that has been confirmed to run 70- 85% of DIMI clinical trial- kept secret.
"Existing Strategic Commercial Partner"
Announced Oct. 5 2022
Spectral announces funding through note offering with "existing strategic commercial partner", but again name of the commercial partner- kept secret.
So, what would Spectral's share price be if the market knew the size of Baxter's finnancial commitment to Spectral and PMX?
What would the SP be if the market knew someone like DaVita was their clinical trial partner for 70- 85% of the DIMI trial?
Or if the market knew that someone like Baxter was now adding to their Spectral Investment?
Is it then fair, or even legal that Spectral raise at a measly 40 cents while withholding this material information back?
Baxter Exclusive Distribution Deal
https://www.baxter.com/baxter-newsroom/baxter-and-spectral-medical-announce-exclusive-distribution-agreement-blood-filter
Confirmed Partner #2
https://spectraldx.com/wp-content/uploads/2022/06/spectral-agm-2022-presentation.pdf
"Existing Strategic Commercial Partner"
https://www.globenewswire.com/news-release/2022/10/05/2529067/0/en/Spectral-Medical-Inc-Announces-Proposed-Public-Offering-of-Units-and-Private-Placement-of-Notes.html